Objective: The aim of this study is to compare the antiemetic effects of intravenous granisetron 40mcg/kg versus 8 mg dexamethasone for prevention of postoperative nausea and vomiting (PONV) in patients undergoing gynaecologic laparoscopic surgeries. Subject and Methods: In this prospective comparative study, a total of 64 women recruited for the study who underwent elective abdominal gynaecologic laparoscopic procedures under general anesthesia with endotracheal intubation, 34 patients were assigned to granisetron group (A) and 30 patients were assigned to dexamethasone group (B). Preoperatively all patients were subjected to a thorough medical history, physical examination, laboratory investigations. Postoperatively patients were assessed according to nausea and vomiting score, hemodynamic changes, and the need for rescue antiemetics. Results: After 6 hours and up to 24 hours postoperatively, 6 (20%) patients experienced nausea in group (B) compared to 2 (5.9%) patients in group (A) and 5 (16.7%) patients experienced vomiting in group (B) compared to only one (2.9%) patient in group (A) which was significant (P= 0.05, 0.046) respectively. Anti-emetics were used in 5(16.7%) patients in group (B) compared to only one (2.9%) patient in group (A) which was statistically significant (p= 0.045). Conclusion: Dexamethasone is as effective as granisetron in controlling PONV during the first six hours postoperatively, however during rest of the first day granisetron showed more efficient control of PONV than dexamethasone. On the other hand, dexamethasone could be a good second alternative to granisetron particularly for economic basis in patients undergoing laparoscopic gynaecologic operations despite its expected side effects.
Introduction
Postoperative nausea and vomiting (PONV) is a frequent stressful complication that happens after all types of anesthesia. (1, 2) PONV ranges from mild to severe or transient to persistent , it influences the postoperative outcome greatly and delay recovery and discharge thus increasing financial burden over the hospital especially after day care surgeries. (1) The incidence of nausea and vomiting after gynaecologic laparoscopic surgeries is high (40-77%) due to elevation of the intra-abdominal pressure, rapid peritoneal distension and stretch of peritoneum by insufflation and bowel distension because of carbon dioxide (CO2) diffusion inside it. (3, 4) The risk factors involved in PONV include females, middle age (20-40 years), history of motion sickness, laparoscopic gynaecologic procedures, use of nitrous oxide, opioids and past history of PONV. (5) Multiple areas in the brain and gastro-intestinal tract (GIT) are responsible for the process of PONV. These areas include the chemoreceptor trigger zone (CTZ) in the brain, the vestibular system, visceral afferents from the GIT, and the cerebral cortex. (6) These areas excite the vomiting center in the brain stem, that triggers the salivation center, respiratory center, and the pharyngeal, gastro-intestinal, and abdominal muscles that lead to vomiting. (7) The CTZ has many receptors including serotonin (5-Hydroxytryptamine) type 3 (5-HT 3 ), neurokinin-1 (NK 1 ) and dopamine (D 2 ). Abdominal vagal visceral fibers are flourished by 5-HT 3 receptors which are stimulated by infection, distension, and mucosal irritation. (8) Persistent PONV may lead to tension on suture line, venous hypertension, subcutaneous bleeding, esophageal rupture and jeopardise the patient by increasing the risk of pulmonary aspiration if airway reflexes are not fully recovered due to anaesthetic residual. (9) Various methods to reduce postoperative nausea and vomiting have been tried along the years, which include physical manoeuvres like fasting regimens, pre-anesthetic emptying of stomach, avoiding distension of stomach during non invasive positive pressure ventilation, the use of various antiemetics like Phenothiazines, butyrophenones , antihistaminics , anticholinergics, benzamides, steroids, cannabinoids, and NK1 receptor antagonists. But these drugs have many side effects like sedation, extrapyramidal side effects, and drug interactions. (5, 10) Serotonin (5HT 3 ) receptor antagonists including ondansetron, granisetron, dolasetron and tropisetron showed significant improvement in patient's satisfaction, reduction of recovery time, discharge time and decrease in unexpected hospital admission. Granisetron is highly selective and with more potent and of longer duration of action than that of ondansetron. Granisetron has been used effectively in the treatment of cytotoxic induced vomiting (cisplatin). It has also recently been used effectively in PONV after gynaecologic surgeries and laparoscopies. (11) Dexamethasone is a synthetic steroid that has powerful anti-inflammatory, anti-emetic properties which make it widely used to prevent PONV in surgical patients. It has been initially tried as an anti-emetic in patients on chemotherapy for more than three decades and was first studied in preventing PONV in the early nineties. (12) Although the exact mechanism of action is unclear yet, it has been suggested that the anti-emetic effect could be due to the inhibition of prostaglandin synthesis, prevention of serotonin 5HT 3 release in the gut, decrease in neural 5hydroxytryptophan levels or release of endorphins. (13) The Society for Ambulatory Anaesthesia (SAMBA) guidelines for the management of PONV recommends a prophylactic dose of 4 mg to 5 mg for patients at high risk of PONV regardless of the surgical procedure. (14) The aim of this study is to compare the antiemetic effects of intravenous granisetron 40mcg/kg versus 8 mg dexamethasone for prevention of PONV in patients undergoing gynaecologic laparoscopic surgeries.
Subjects and Methods
 Study Design This prospective comparative study was carried out at Ibn Sina College Hospital, Jeddah, Saudi Arabia from April 2016 till November 2017. A total of 64 women recruited for the study who underwent elective abdominal gynaecologic laparoscopic procedures under general anesthesia with endotracheal intubation, 34 patients were assigned to granisetron group (A) and 30 patients were assigned to dexamethasone group (B). This study was approved by the Hospital Research Ethics Committee and has been performed in accordance with the ethical standards as in Declaration of Helsinki (1964) and its latter amendments, and a written informed consent was obtained prior to the study.
 Inclusion and Exclusion Criteria
The inclusion criteria of these female patients include class I-II according to American society of anaesthesiologists (ASA) physical status, with an age of 20 up to 40 years subjected to laparoscopic gynaecologic procedures. Exclusion criteria include; patients with ASA physical status class III -IV, pregnancy or lactation, severe hypertension , uncontrolled diabetes mellitus, cardiovascular disease, renal disease, any gastric illness, any anti-emetic drug intake during past 24hours, history of relevant drug allergy, any possibility of anticipated difficult intubation. Participants in group (A) received 40 µg/kg granisetron intravenous (I.V) five minutes prior to induction of general anesthesia while participants in group (B) received 8 mg dexamethasone by the same route and at the same time.
 Preoperative Anesthetic Assessment
All patients were subjected to a thorough medical history, physical examination, laboratory investigations (fasting blood sugar, kidney, liver function tests, serum electrolytes, coagulation profile, and electrocardiogram) preoperatively. They were also counselled about the anesthetic management and potential complications of both surgery and anesthesia. All these data were documented. A thorough airway assessment by Mallampati classification, mouth opening, neck movement, thyromental distance was done to find out any possibility of difficult intubation. If there was a chance of significant difficult intubation, the patient was excluded from the study. Adequate fasting of all the patients for at least 6 hours preoperatively should be confirmed. The patients were familiarized with a post-operative nausea and vomiting score, described as: 1=
No nausea or vomiting. 2=
Mild nausea (not requiring rescue antiemetic) 3=
Severe nausea (requiring rescue antiemetic) 4=
Mild vomiting (<2 vomiting episodes) , requiring rescue antiemetic 5=
Severe vomiting (> 2 vomiting episodes), requiring rescue antiemetic.
 Anesthetic Protocol
All patients premedicated with midazolam 0.02 mg/kg I.V one hour preoperatively. The studied drugs are given intravenously 5 minutes before induction of general anesthesia. General anesthesia started after pre-oxygenation for 3 minutes, it was induced with I.V thiopental 5 mg/kg, atracurium 0.5 mg /Kg then patients were intubated and then atracurium 0.2 mg/kg was given for maintenance of muscle relaxation based on using a peripheral nerve stimulator. Anesthesia was continued by mixture of O2 and N2O along with 2% sevoflurane. All patients received tramadol (1 mg/kg) for intra operative analgesia, and were mechanically ventilated to keep EtCO2 between 35-40 mm Hg. An oro-gastric tube was inserted to make the stomach empty of air and other contents. Peritoneal cavity was insufflated with carbon dioxide to keep intra-abdominal pressure <14 mmHg. At the end of procedure the muscle relaxant was antagonized by 40µg/kg neostigmine and 20µg/kg atropine I.V. The orogastric tube was suctioned and then removed prior to tracheal extubation, then awake extubation was done and the patients were transferred to the recovery unit. Intramuscular diclofenac was given for postoperative analgesia.
 Patients Assessment
The patients were assessed in terms of: 1. All episodes of PONV (nausea, retching and vomiting) were recorded and classified according to nausea and vomiting score for 0-2 hours in post anaesthesia care unit and from 3-24 hours in postoperative ward. Patients with severe nausea and one or more episodes of vomiting were rescued with antiemetic metoclopramide 0.2 mg/kg I.V. 
Statistical Analysis
The Data was collected and entered into the personal computer. Statistical analysis was done using Statistical Package for Social Sciences (SPSS/version 20) software. Arithmetic mean, standard deviation, t-test was used to compare the two groups. The level of significance was 0.05. Sample size calculation: Sample size was calculated based on previous studies and by using Med Calc statistical software. Assuming area under ROC to be 0.80, an alpha of 0.05 and power of study 90.0%. A minimum sample size required was calculated to be 60 patients for this study.
Results
A total of 64 women recruited for this prospective comparative study who underwent elective laparoscopic gynaecologic procedures under general anaesthesia, 34 patients were assigned to granisetron group (A) and 30 patients were assigned to dexamethasone group (B). The demographic characteristics of the study participants are illustrated in table (1) . There were no statistically significant differences between the two groups for maternal age, body mass index (BMI), parity, and smoking. Operative variables particularly duration of surgery and anaesthesia were calculated. The mean duration of surgery was 62.5±9.25 minutes in group (A) compared to 65.7±8.25 minutes in group (B). On the other hand, the mean duration of anaesthesia was 73.3±5.98 minutes in group (A) compared to 78.4±6.58 minutes in group (B). These variables showed insignificant differences between two groups. (Table 1) Regarding gynecologic indications for laparoscopic surgeries, 27(42.2%) participants were admitted for ovarian cystectomy, 24(37.5%) participants for diagnostic laparoscopy, 8(12.5%) participants for ovarian drilling, and 5 (7.8%) participants for other indications. (Figure 1 ) Concerning the incidence of postoperative nausea and vomiting during the first six hours, there were no statistically significant differences between both groups. (Table 2) 
Figure (1): Types of laparoscopic surgeries in both groups

Discussion
PONV is a very distressing problem to the patient and is quite common in patients undergoing gynaecologic laparoscopic surgeries. (2) Many previous studies discussed the potent anti-emetic effects of granisetron postoperatively (15) , Fujii et al (16) , recommended the use of granisetron in an I.V dose of 40 µg/kg which is more effective than lower dose (20 µg/Kg) and at the same time, it has the same effectiveness of 60 μg/ kg in controlling PONV. Wadaskar et al (17) , also revealed that 40μg/kg granisetron intravenously was safer, more efficient, and cost effective than ondansetron for prevention of PONV in patients undergoing gynaecologic laparoscopic surgeries under general anesthesia. On the other hand dexamethasone has an established role for the prevention of PONV and it was proved to be as effective and safe as ondansetron in a meta analysis done by Wang et al (18) , over 608 patients undergoing laparoscopic surgeries, and marginally better than droperidol and cyclizine in addition to remarkable opioid sparing effects. (19) In the present study, we compared the beneficial anti-emetic postoperative effects of I.V 40 µg/kg granisetron versus 8 mg dexamethasone after gynecologic laparoscopic surgeries, and we preferred to use PONV score due to its easiness to understand by the patients and feasibility of its application and evaluation. In our study the incidence of total PONV was (5.9%), (8.8%) in group (A) versus (10%), (36.7%) in group (B) at 0-6 hours and 6-24 hours respectively, which reveals that granisetron has more potent antiemetic effect than dexamethasone over the first 24 hours postoperatively. Although the results of many previous studies as Fukami et al (20) , Binachin et al (21) , Feo et al (22) , and Bisgard et al (23) , proved that dexamethasone preoperatively in laparoscopic surgeries provided considerable reduction of PONV with doubtful effect on post operative pain which actually is in agreement with our results in the first 6 postoperative hours only, but it has not significant antiemetic effect in the next 18 hours postoperatively. From the opposed point of view, our results contradict other previous studies as Hessami M and Yari M (24) , done on 104 patients and reported that 3 mg granisetron or 8 mg dexamethasone preoperatively had similar effects in prophylaxis of nausea and vomiting after laparoscopic cholecystectomy, and Erhan et al (25) , they mentioned that injection of 8 mg dexamethasone is more effective than 3 mg granisetron in PONV prophylaxis but the differences were statistically insignificant. The similar anti-emetic effect of dexamethasone to granisetron could be explained by the inhibition of prostaglandin synthesis, prevention of serotonin 5HT 3 release in the gut, decrease in neural 5HT 3 levels or release of endorphins. (26) 
Conclusion
We concluded that dexamethasone is as effective as granisetron in controlling PONV during the first six hours postoperatively, however during rest of the first day granisetron showed more efficient control of PONV than dexamethasone. On the other hand, dexamethasone could be a good second alternative to granisetron particularly for economic basis in patients undergoing laparoscopic gynaecologic operations despite its expected side effects.
